Skip to main content
Springer Nature Link
Log in

SARS-COV-2 vaccine inactivated Sinovac Biotech/Tozinameran

Skin disorders: 25 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

SARS-COV-2 vaccine inactivated Sinovac Biotech/Tozinameran. Reactions Weekly 2027, 456 (2024). https://doi.org/10.1007/s40278-024-67645-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-67645-y